Literature DB >> 2110186

Immortalization of murine microglial cells by a v-raf/v-myc carrying retrovirus.

E Blasi1, R Barluzzi, V Bocchini, R Mazzolla, F Bistoni.   

Abstract

A murine cell line (BV-2) has been generated by infecting primary microglial cell cultures with a v-raf/v-myc oncogene carrying retrovirus (J2). BV-2 cells expressed nonspecific esterase activity, phagocytic ability and lacked peroxidase activity. Such cells secreted lysozyme and, following appropriate stimulation, also interleukin 1 and tumor necrosis factor. Furthermore, BV-2 cells exhibited spontaneous anti-Candida activity and acquired tumoricidal activity upon treatment with interferon-gamma. Phenotypically, BV-2 cells resulted positive for MAC1 and MAC2 antigens, and negative for MAC3, glial fibrillary acidic protein (GFAP) and galactocerebroside (GC) antigens. Since BV-2 cells retain most of the morphological, phenotypical and functional properties described for freshly isolated microglial cells, we can conclude that J2 virus infection has resulted in the immortalization of active microglial cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2110186     DOI: 10.1016/0165-5728(90)90073-v

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  351 in total

1.  Microglial Toll-like receptor 2 contributes to kainic acid-induced glial activation and hippocampal neuronal cell death.

Authors:  Jinpyo Hong; Ik-Hyun Cho; Kyung Il Kwak; Eun Cheng Suh; Jinsoo Seo; Hyun Jung Min; Se-Young Choi; Chong-Hyun Kim; Seung Hwa Park; Eun-Kyeong Jo; Soojin Lee; Kyung Eun Lee; Sung Joong Lee
Journal:  J Biol Chem       Date:  2010-10-05       Impact factor: 5.157

2.  Impact of endogenous nitric oxide on microglial cell energy metabolism and labile iron pool.

Authors:  Benoît Chénais; Hamid Morjani; Jean-Claude Drapier
Journal:  J Neurochem       Date:  2002-05       Impact factor: 5.372

3.  Estrogen and P2 Purinergic Receptor Systems in Microglia: Therapeutic Targets for Neuroprotection.

Authors:  Jessica M Crain; Jyoti J Watters
Journal:  Open Drug Discov J       Date:  2010-01-01

4.  Development of a strand specific real-time RT-qPCR assay for the detection and quantitation of murine norovirus RNA.

Authors:  Surender Vashist; Luis Urena; Ian Goodfellow
Journal:  J Virol Methods       Date:  2012-05-22       Impact factor: 2.014

5.  Generation of microglial cells from mouse embryonic stem cells.

Authors:  Clara Beutner; Kristin Roy; Bettina Linnartz; Isabella Napoli; Harald Neumann
Journal:  Nat Protoc       Date:  2010-08-05       Impact factor: 13.491

6.  A novel compound PTIQ protects the nigral dopaminergic neurones in an animal model of Parkinson's disease induced by MPTP.

Authors:  Hyo Jin Son; Ji Ae Lee; Nari Shin; Ji Hyun Choi; Jai Woong Seo; Dae Yoon Chi; Cheol Soon Lee; Eun-Mee Kim; Han Choe; Onyou Hwang
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

7.  LPS and IL-1 differentially activate mouse and human astrocytes: role of CD14.

Authors:  Leonid Tarassishin; Hyeon-Sook Suh; Sunhee C Lee
Journal:  Glia       Date:  2014-03-21       Impact factor: 7.452

8.  Synthesis and biological evaluation of substituted N-[3-(1H-pyrrol-1-yl)methyl]-1,2,5,6-tetrahydropyridin-1-yl]benzamide/benzene sulfonamides as anti-inflammatory agents.

Authors:  Madhavi Gangapuram; Elizabeth Mazzio; Suresh Eyunni; Karam F A Soliman; Kinfe K Redda
Journal:  Arch Pharm (Weinheim)       Date:  2014-03-02       Impact factor: 3.751

9.  Thymoquinone increases the expression of neuroprotective proteins while decreasing the expression of pro-inflammatory cytokines and the gene expression NFκB pathway signaling targets in LPS/IFNγ -activated BV-2 microglia cells.

Authors:  Makini K Cobourne-Duval; Equar Taka; Patricia Mendonca; Karam F A Soliman
Journal:  J Neuroimmunol       Date:  2018-05-04       Impact factor: 3.478

10.  HIV-1 gp120 Upregulates Brain-Derived Neurotrophic Factor (BDNF) Expression in BV2 Cells via the Wnt/β-Catenin Signaling Pathway.

Authors:  Yongdi Wang; Jinxu Liao; Shao-Jun Tang; Jianhong Shu; Wenping Zhang
Journal:  J Mol Neurosci       Date:  2017-05-30       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.